← back to search
Panagiotis Flevaris
Eli Lilly (United States) · US
Area of research
Immunology and Allergy · Cancer Research
Research interest
Research interests include Cell Adhesion Molecules Research, Protease and Inhibitor Mechanisms, Cardiac Fibrosis and Remodeling, and Sexual function and dysfunction studies.
h-index
14
citations
1,676
works
20
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗
Recent publications
Cardiovascular Safety of Testosterone-Replacement Therapy
New England Journal of Medicine
2023
cited by
408
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Anna Chan
· Chinese University of Hong Kong
1
papers (2023–2023)
Nader Khan
· AbbVie (United States)
1
papers (2023–2023)
A. Michael Lincoff
· Cleveland Clinic
1
papers (2023–2023)
Mohit Khera
· Baylor College of Medicine
1
papers (2023–2023)
Glenn R. Cunningham
· VA Boston Healthcare System
1
papers (2023–2023)
Christopher B. Granger
· Duke University
1
papers (2023–2023)
Ian M. Thompson
· Campbell Center for Historic Preservation Studies
1
papers (2023–2023)
Karol M. Pencina
· Harvard University
1
papers (2023–2023)
Deborah Davey
· University of San Francisco
1
papers (2023–2023)
Steven E. Nissen
· Esperion Therapeutics (United States)
1
papers (2023–2023)
Elena Dubcenco
· AbbVie (United States)
1
papers (2023–2023)
Shehzad Basaria
· Harvard University
1
papers (2023–2023)
Vidyasagar Kalahasti
· Cleveland Clinic
1
papers (2023–2023)
William E. Boden
· Boston University
1
papers (2023–2023)
Kathy Wolski
· Cleveland Clinic
1
papers (2023–2023)
Shalender Bhasin
· Harvard University
1
papers (2023–2023)
Michael G. Miller
· St. Mary's Medical Center
1
papers (2023–2023)
Bidan Huang
· Qingdao University
1
papers (2023–2023)
Thomas G. Travison
· Harvard University
1
papers (2023–2023)
Lisa M. Mitchell
· Western University
1
papers (2023–2023)